BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 32332061)

  • 1. Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2.
    Zhen W; Smith E; Manji R; Schron D; Berry GJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32332061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Four Molecular
    Zhen W; Manji R; Smith E; Berry GJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32341143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
    Loeffelholz MJ; Alland D; Butler-Wu SM; Pandey U; Perno CF; Nava A; Carroll KC; Mostafa H; Davies E; McEwan A; Rakeman JL; Fowler RC; Pawlotsky JM; Fourati S; Banik S; Banada PP; Swaminathan S; Chakravorty S; Kwiatkowski RW; Chu VC; Kop J; Gaur R; Sin MLY; Nguyen D; Singh S; Zhang N; Persing DH
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32366669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Accula SARS-CoV-2 Test with a Laboratory-Developed Assay for Detection of SARS-CoV-2 RNA in Clinical Nasopharyngeal Specimens.
    Hogan CA; Garamani N; Lee AS; Tung JK; Sahoo MK; Huang C; Stevens B; Zehnder J; Pinsky BA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32461285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.
    Smithgall MC; Scherberkova I; Whittier S; Green DA
    J Clin Virol; 2020 Jul; 128():104428. PubMed ID: 32434706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Evaluation and Utilization of Multiple Molecular In Vitro Diagnostic Assays for the Detection of SARS-CoV-2.
    Cradic K; Lockhart M; Ozbolt P; Fatica L; Landon L; Lieber M; Yang D; Swickard J; Wongchaowart N; Fuhrman S; Antonara S
    Am J Clin Pathol; 2020 Jul; 154(2):201-207. PubMed ID: 32462195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
    Moran A; Beavis KG; Matushek SM; Ciaglia C; Francois N; Tesic V; Love N
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303565
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay.
    Wong RC; Wong AH; Ho YI; Leung EC; Lai RW
    J Clin Virol; 2020 Oct; 131():104593. PubMed ID: 32823131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Assay for the Detection of SARS-CoV-2 in Oropharyngeal Swab Specimens.
    Hou H; Chen J; Wang Y; Lu Y; Zhu Y; Zhang B; Wang F; Mao L; Tang YW; Hu B; Ren Y; Sun Z
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32503847
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of Commercially Available and Laboratory-Developed Assays for
    Lieberman JA; Pepper G; Naccache SN; Huang ML; Jerome KR; Greninger AL
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32350048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Saliva as an Alternate Specimen Source for Detection of SARS-CoV-2 in Symptomatic Patients Using Cepheid Xpert Xpress SARS-CoV-2.
    McCormick-Baw C; Morgan K; Gaffney D; Cazares Y; Jaworski K; Byrd A; Molberg K; Cavuoti D
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32414838
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of a Point-of-Care Assay and a High-Complexity Assay for Detection of SARS-CoV-2 RNA.
    Stevens B; Hogan CA; Sahoo MK; Huang C; Garamani N; Zehnder J; Kurzer J; Pinsky BA
    J Appl Lab Med; 2020 Nov; 5(6):1307-1312. PubMed ID: 32761092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test Agreement between Roche Cobas 6800 and Cepheid GeneXpert Xpress SARS-CoV-2 Assays at High Cycle Threshold Ranges.
    Broder K; Babiker A; Myers C; White T; Jones H; Cardella J; Burd EM; Hill CE; Kraft CS
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32444354
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparison of Abbott ID Now, DiaSorin Simplexa, and CDC FDA Emergency Use Authorization Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Individuals Diagnosed with COVID-19.
    Rhoads DD; Cherian SS; Roman K; Stempak LM; Schmotzer CL; Sadri N
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303564
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical evaluation of the BioFire® Respiratory Panel 2.1 and detection of SARS-CoV-2.
    Creager HM; Cabrera B; Schnaubelt A; Cox JL; Cushman-Vokoun AM; Shakir SM; Tardif KD; Huang ML; Jerome KR; Greninger AL; Drobysheva D; Spaulding U; Rogatcheva M; Bourzac KM; Hinrichs SH; Broadhurst MJ; Fey PD
    J Clin Virol; 2020 Aug; 129():104538. PubMed ID: 32650276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analytical and Clinical Comparison of Three Nucleic Acid Amplification Tests for SARS-CoV-2 Detection.
    Smith E; Zhen W; Manji R; Schron D; Duong S; Berry GJ
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32571894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Abbott ID Now and Abbott m2000 Methods for the Detection of SARS-CoV-2 from Nasopharyngeal and Nasal Swabs from Symptomatic Patients.
    Harrington A; Cox B; Snowdon J; Bakst J; Ley E; Grajales P; Maggiore J; Kahn S
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32327448
    [No Abstract]   [Full Text] [Related]  

  • 20. Direct Comparison of SARS-CoV-2 Analytical Limits of Detection across Seven Molecular Assays.
    Fung B; Gopez A; Servellita V; Arevalo S; Ho C; Deucher A; Thornborrow E; Chiu C; Miller S
    J Clin Microbiol; 2020 Aug; 58(9):. PubMed ID: 32651238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.